0
0
Home » Pharmaceuticals

Alopecia – Global Clinical Trials Review, 2022

The alopecia clinical trials report provides a comprehensive overview of the alopecia clinical trials landscape. The report includes an overview of trials count and their average enrollment in top countries conducted globally. The report includes coverage of disease clinical trials by region and top countries, trial phase, trial status, end points status and sponsor type. The report also provides prominent drug names and trial counts for in-progress trials (based on number of ongoing trials).

What are the market dynamics in the alopecia clinical trial market?

Alopecia clinical trials report consists of more than 600 trials. Trials conducted by companies are in Phase IV, Phase III, Phase II, Phase I and Phase 0. Similarly, the trials with different status compile of completed, ongoing, planned, terminated and withdrawn.

Which are the key regions in the alopecia clinical trial market?

The key regions in the alopecia clinical trials market are Asia-Pacific, Middle East & Africa, Europe, North America, and Central & South America.

Alopecia clinical trials market in Asia- Pacific

India, China, Japan, South Korea, and Thailand are the key countries in the alopecia clinical trials market in Asia – Pacific. India has the highest number of clinical trials followed by China, Japan, South Korea and Thailand.

Alopecia clinical trials market in Europe

Germany, France, Russia, Belgium, and the United Kingdom are the key countries in Europe in the alopecia clinical trials market. Germany has the highest number of clinical trials among them, followed by France, Russia, Belgium and the UK.

Alopecia clinical trials market in North America

The US, Canada, and Mexico are the key countries in the alopecia clinical trials market in North America. The US has the highest number of clinical trials in the region, followed by Canada and Mexico.

Alopecia clinical trials market in Middle East & Africa

Iran, Egypt, Israel, Kuwait, and Lebanon are the key countries in Middle East & Africa in the alopecia clinical trials market. Among them Iran has the highest number of clinical trials of alopecia, followed by Egypt, Israel, and Kuwait.

Alopecia clinical trials market in Central & South America

Brazil, Argentina, Chile, Colombia, and Peru are the key countries in the alopecia clinical trials market in Central & South America. Brazil has the highest number of clinical trials, followed by Argentina, Chile, Colombia, and Peru.

Alopecia clinical trials market in G7 countries

The G7 countries include the US, the UK, Germany, France, Italy, Canada, and Japan. Among them the US has the highest number of clinical trials of alopecia.

Alopecia clinical trials market in E7 countries

China, India, Russia, Brazil, Mexico, Turkey, and Indonesia are the E7 countries. Among them India has the highest number of clinical trials of alopecia.

Alopecia clinical trials market, by region

Alopecia clinical trials market, by region

For more regional insights, download a free sample

Who are the key sponsors in the alopecia clinical trial market?

Pfizer Inc, Concert Pharmaceuticals Inc, Johnson & Johnson, AbbVie Inc, Aclaris Therapeutics Inc, Kintor Pharmaceutical Ltd, Applied Biology Inc, Dr. Reddy’s Laboratories Ltd, GlaxoSmithKline Plc, and Almirall SA are the key sponsors in the alopecia clinical trial market.

Alopecia clinical trials market, by key sponsors

Alopecia clinical trials market, by key sponsors

To know more about key sponsors, download a free sample

Market report scope

Key regions Asia-Pacific, Europe, North America, Middle East & Africa, and Central & South America
Key phases Phase IV, Phase III/IV, Phase III, Phase II/III, Phase II, Phase I/II, Phase I, and Phase 0
Key sponsors Pfizer Inc, Concert Pharmaceuticals Inc, Johnson & Johnson, AbbVie Inc, Aclaris Therapeutics Inc, Kintor Pharmaceutical Ltd, Applied Biology Inc, Dr. Reddy’s Laboratories Ltd, GlaxoSmithKline Plc, and Almirall SA

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by region, country (G7 & E7), trial status, trial phase, sponsor type and end point status
  • The report reviews top companies involved and enlists all trials (trial title, phase, and status) pertaining to the company
  • The report provides all the unaccomplished trials (terminated, suspended and withdrawn) with reason for failure
  • The report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to Buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of global clinical trials market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Key Players

Pfizer Inc

Concert Pharmaceuticals Inc

Johnson & Johnson

AbbVie Inc

Aclaris Therapeutics Inc

Kintor Pharmaceutical Ltd

Applied Biology Inc

Dr. Reddy’s Laboratories Ltd

GlaxoSmithKline Plc

Almirall SA

Table of Contents

Table of Contents

Report Guidance

GlobalData Clinical Trials Report Coverage

Clinical Trials by Region

Clinical Trials and Average Enrollment by Country

Top Five Countries Contributing to Clinical Trials in Asia-Pacific

Top Five Countries Contributing to Clinical Trials in Europe

Top Countries Contributing to Clinical Trials in North America

Top Five Countries Contributing to Clinical Trials in Middle East and Africa

Top Five Countries Contributing to Clinical Trials in Central and South America

Clinical Trials by G7 Countries: Proportion of Alopecia to Dermatology Clinical Trials

Clinical Trials by Phase in G7 Countries

Clinical Trials in G7 Countries by Trial Status

Clinical Trials by E7 Countries: Proportion of Alopecia to Dermatology Clinical Trials

Clinical Trials by Phase in E7 Countries

Clinical Trials in E7 Countries by Trial Status

Clinical Trials by Phase

In Progress Trials by Phase

Clinical Trials by Trial Status

Clinical Trials by End Point Status

Subjects Recruited Over a Period of Time

Clinical Trials by Sponsor Type

Prominent Sponsors

Top Companies Participating in Alopecia Therapeutics Clinical Trials

Prominent Drugs

Clinical Trial Profile Snapshots

Appendix

Abbreviations

Definitions

Research Methodology

Secondary Research

About GlobalData

Contact Us

Source

List of Tables

List of Tables

Alopecia Therapeutics, Global, Clinical Trials by Region, 2022*

Alopecia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2022*

Alopecia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2022*

Alopecia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2022*

Alopecia Therapeutics Clinical Trials, Europe, Top Five Countries, 2022*

Alopecia Therapeutics Clinical Trials, North America, Top Countries, 2022*

Alopecia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2022*

Alopecia Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2022*

Proportion of Alopecia to Dermatology Clinical Trials, G7 Countries (%), 2022*

Alopecia Therapeutics, G7 Countries, Clinical Trials by Phase, 2022*

Alopecia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2022*

Proportion of Alopecia to Dermatology Clinical Trials, E7 Countries (%), 2022*

Alopecia Therapeutics, E7 Countries, Clinical Trials by Phase, 2022*

Alopecia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2022*

Alopecia Therapeutics, Global, Clinical Trials by Phase, 2022*

Alopecia Therapeutics, Global, Clinical Trials In Progress by Phase 2022*

Alopecia Therapeutics, Global, Clinical Trials by Trial Status, 2022*

Alopecia Therapeutics Clinical Trials, Global, by End Point Status, 2022*

Alopecia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2017-2021

Alopecia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2022*

Alopecia Therapeutics Clinical Trials, Global, Key Sponsors, 2022*

Alopecia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2022*

Alopecia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2022*

List of Figures

List of Figures

Alopecia Therapeutics, Global, Clinical Trials by Region (%), 2022*

Alopecia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2022*

Alopecia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2022*

Alopecia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2022*

Alopecia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2022*

Alopecia Therapeutics Clinical Trials, North America, Top Countries (%), 2022*

Alopecia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2022*

Alopecia Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2022*

Proportion of Alopecia to Dermatology Clinical Trials, G7 Countries (%), 2022*

Alopecia Therapeutics, G7 Countries, Clinical Trials by Phase, 2022*

Alopecia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2022*

Proportion of Alopecia to Dermatology Clinical Trials, E7 Countries (%), 2022*

Alopecia Therapeutics, E7 Countries, Clinical Trials by Phase, 2022*

Alopecia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2022*

Alopecia Therapeutics, Global, Clinical Trials by Phase (%), 2022*

Alopecia Therapeutics, Global, Clinical Trials In Progress by Phase, 2022*

Alopecia Therapeutics, Global, Clinical Trials by Trial Status, 2022*

Alopecia Therapeutics Clinical Trials, Global, by End Point Status, 2022*

Alopecia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2017-2021

Alopecia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2022*

Alopecia Therapeutics Clinical Trials, Global, Key Sponsors, 2022*

Alopecia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2022*

Alopecia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2022*

GlobalData Methodology

Frequently Asked Questions

Asia-Pacific, Europe, North America, Middle East & Africa, and Central & South America are the key regions in the alopecia clinical trials market.

The key phases in the alopecia clinical trials market are Phase IV, Phase III/IV, Phase III, Phase II/III, Phase II, Phase I/II, Phase I, and Phase 0

The key sponsors in the alopecia clinical trials market are Pfizer Inc, Concert Pharmaceuticals Inc, Johnson & Johnson, AbbVie Inc, Aclaris Therapeutics Inc, Kintor Pharmaceutical Ltd, Applied Biology Inc, Dr. Reddy’s Laboratories Ltd, GlaxoSmithKline Plc, and Almirall SA

    Pricing

Discounts available for multiple purchases.

reportstore@globaldata.com
+44 20 7947 2960

Join our mailing list

Saved reports